Shalapour and colleagues have recently reported that IgA+ plasma cells associated with NASH-derived HCC have an immunosuppressive phenotype characterized by the expression of PD-L1 and IL-10 and that they inhibit CD8+ T-cell activation [86]. The gene discussed is CD79A; the disease is metabolic dysfunction-associated steatohepatitis.